Neogen Corp (NEOG) shareholders
Close on Nov 17, 2026Market cap $2.38BP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 30,944,709 | 14.30% | 13G (passive) amendment | Mar 31, 2025 |
| Neuberger Berman Group LLC Joint filing with Neuberger Berman Investment Advisers LLC (7.40%) | 16,570,795 | 7.60% | 13G (passive) | Jun 30, 2026 |
| ING Capital Markets LLC Joint filing with Ing Groep Nv (6.47%) | 14,060,900 | 6.47% | 13G (passive) | Sep 29, 2025 |
| Jeremy J. Modell Joint filing with Clarkston Capital Partners, LLC (6.44%), Clarkston Companies, Inc. (6.44%) and 3 more | 14,005,725 | 6.44% | 13G (passive) | Jun 30, 2025 |
| Vanguard Portfolio Management | 12,916,330 | 5.93% | 13G (passive) | Mar 31, 2026 |
| Vanguard Capital Management | 11,164,628 | 5.13% | 13G (passive) | Mar 31, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of NEOG | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 33,431,015 | 15.31% | $300.54M | +810,010 | 0.00% |
| Neuberger Berman Group LLC | 16,570,795 | 7.59% | $149.00M | +8,819,077 | 0.10% |
| Vanguard Portfolio Management LLC | 13,038,732 | 5.97% | $117.22M | +206,468 | 0.01% |
| Dimensional Fund Advisors LP | 9,828,174 | 4.50% | $88.36M | +696,153 | 0.02% |
| Vanguard Capital Management LLC | 9,655,248 | 4.42% | $86.80M | +90,202 | 0.00% |
| SG Americas Securities, LLC | 9,352,065 | 4.28% | $84.08M | +3,086,032 | 0.05% |
| T. Rowe Price Investment Management, Inc. | 9,333,261 | 4.28% | $83.91M | −829,454 | 0.05% |
| Ing Groep Nv | 9,102,300 | 4.17% | $81.83M | +198,000 | 0.40% |
| State Street Corp | 8,946,377 | 4.10% | $80.43M | +356,033 | 0.00% |
| Gates Capital Management, Inc. | 8,742,274 | 4.00% | $78.59M | +2,483,625 | 1.89% |
| Hudson Bay Capital Management LP | 6,500,000 | 2.98% | $58.44M | −180 | 0.16% |
| Geode Capital Management, LLC | 5,832,899 | 2.67% | $52.45M | +271,286 | 0.00% |
| Bamco Inc /Ny/ | 5,015,968 | 2.30% | $45.09M | +6,309 | 0.07% |
| Morgan Stanley | 4,306,091 | 1.97% | $38.71M | −274,336 | 0.00% |
| Mizuho Markets Americas LLC | 4,250,000 | 1.95% | $38.21M | +750,000 | 0.60% |
| National Bank Of Canada /Fi/ | 4,000,000 | 1.83% | $35.96M | +500,000 | 0.03% |
| CIBC Bancorp USA Inc. | 3,549,006 | 1.63% | $31.91M | −2,444,216 | 0.04% |
| Cibc World Market Inc. | 3,500,500 | 1.60% | $31.47M | −2,461,100 | 0.05% |
| Healthcare Of Ontario Pension Plan Trust Fund | 3,488,246 | 1.60% | $31.36M | +190,900 | 0.04% |
| MUFG Securities EMEA plc | 3,320,011 | 1.52% | $29.85M | −680,000 | 0.31% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 316 | 237M | 100.0% | 54 / 96 | 109 / 38 | 31M | 26M |
| Q1 2026 | 307 | 233M | 100.0% | 46 / 103 | 95 / 38 | 70M | 30M |
| Q4 2025 | 305 | 224M | 100.0% | 48 / 89 | 110 / 40 | 33M | 43M |
| Q3 2025 | 299 | 240M | 100.0% | 46 / 96 | 117 / 62 | 52M | 53M |
| Q2 2025 | 317 | 242M | 100.0% | 66 / 113 | 99 / 85 | 54M | 84M |
| Q1 2025 | 339 | 273M | 100.0% | 51 / 117 | 118 / 50 | 42M | 43M |
| Q4 2024 | 343 | 275M | 100.0% | 46 / 116 | 129 / 35 | 37M | 19M |
| Q3 2024 | 337 | 257M | 100.0% | 28 / 128 | 118 / 30 | 43M | 15M |
| Q2 2024 | 345 | 255M | 100.0% | 55 / 126 | 108 / 51 | 29M | 31M |
| Q1 2024 | 343 | 257M | 100.0% | 45 / 102 | 132 / 38 | 35M | 19M |
| Q4 2023 | 340 | 241M | 100.0% | 37 / 112 | 144 / 57 | 36M | 17M |
| Q3 2023 | 366 | 223M | 100.0% | 51 / 106 | 139 / 23 | 8M | 14M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
266 funds held NEOG in Q2 2026, 52% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of NEOG | Value | % of fund | As of |
|---|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 13,117,003 | 6.01% | $117.92M | 0.11% | Jun 30, 2026 |
| Neuberger Genesis Fund | 7,052,940 | 3.23% | $63.26M | 0.86% | May 31, 2026 |
| Vanguard Total Stock Market Index Fund | 6,928,358 | 3.17% | $62.29M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 5,769,816 | 2.64% | $51.87M | 0.06% | Jun 30, 2026 |
| Baron Small Cap Fund | 5,000,000 | 2.29% | $44.95M | 1.58% | Jun 30, 2026 |
| Vanguard Small-Cap Index Fund | 4,987,158 | 2.28% | $44.83M | 0.02% | Jun 30, 2026 |
| Vanguard Small-Cap Value Index Fund | 3,162,296 | 1.45% | $28.43M | 0.04% | Jun 30, 2026 |
| U.S. Small Cap Value Portfolio | 2,944,922 | 1.35% | $35.46M | 0.18% | Jul 31, 2026 |
| Vanguard Extended Market Index Fund | 2,500,594 | 1.15% | $22.48M | 0.02% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 2,421,105 | 1.11% | $29.15M | 0.09% | Jul 31, 2026 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 2,387,568 | 1.09% | $21.46M | 0.23% | Jun 30, 2026 |
| iShares Russell 2000 Value ETF | 2,065,371 | 0.95% | $18.57M | 0.13% | Jun 30, 2026 |
| State Street(R) SPDR(R) Portfolio S&P 600(TM) Small Cap ETF | 2,001,396 | 0.92% | $17.99M | 0.11% | Jun 30, 2026 |
| iShares S&P Small-Cap 600 Value ETF | 1,874,108 | 0.86% | $16.85M | 0.21% | Jun 30, 2026 |
| Small Cap Equity Portfolio | 1,557,529 | 0.71% | $18.75M | 1.80% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Mikheal Nassif | CEO, Director | 27,234 | 0.01% | Oct 9, 2026 |
| Jeremy Yarwood | Chief Scientific Officer | 297 | 0.00% | Nov 4, 2026 |
| Joe B. Freels | Chief Commercial Officer | 6,345 | 0.00% | Nov 3, 2026 |
| Kevin M. Burke | Chief HR Officer | 12,929 | 0.01% | Oct 30, 2026 |
| Gregory S. Hastings | VP, Animal Health | 33,449 | 0.02% | Oct 30, 2026 |
| James A. Walter | SVP of Manufacturing | 28,955 | 0.01% | Oct 21, 2026 |
| John Patrick Moylan | Chief Accounting Officer | 29,331 | 0.01% | Aug 20, 2026 |
| Richard Bryan Riggsbee | CFO | 51,502 | 0.02% | Aug 14, 2026 |
| Jennifer Evans Stacey | Chief Legal Officer | 38,627 | 0.02% | Aug 14, 2026 |
| Tamara A. Ranalli | Senior Vice President | 25,751 | 0.01% | Aug 14, 2026 |
| Amy M. Rocklin | Former Chief Legal Officer | 82,182 | 0.04% | May 19, 2026 |
| David H. Naemura | Former CFO | 93,936 | 0.04% | Dec 2, 2025 |
| John Edward Adent | Former CEO | 371,608 | 0.17% | Oct 28, 2025 |
| Douglas Edward Jones | Former COO | 104,362 | 0.05% | Oct 28, 2025 |
| Catherine E. Woteki | Director | 29,507 | 0.01% | Oct 30, 2026 |
| Rafael A. Rodriguez | Director | 31,211 | 0.01% | Oct 30, 2026 |
| Aashima Gupta | Director | 38,180 | 0.02% | Oct 30, 2026 |
| Ronald D. Green | Director | 29,044 | 0.01% | Oct 30, 2026 |
| James C. Borel | Director | 106,737 | 0.05% | Oct 30, 2026 |
| Jeffrey D. Capello | Director | 42,892 | 0.02% | Oct 30, 2026 |
| Andrea F. Wainer | Director | 11,834 | 0.01% | Oct 2, 2026 |
| Avi Pelossof | Director | 9,804 | 0.00% | Oct 2, 2026 |
| William T. Boehm | Director | 47,913 | 0.02% | Oct 28, 2025 |
| James P. Tobin | Director | 43,347 | 0.02% | Oct 28, 2025 |
| Thierry Bernard | Director | 19,769 | 0.01% | Oct 27, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Jeremy Yarwood Chief Scientific Officer | Nov 4, 2026 | Sale | −9,051 | $12.67 | $114.68K | 0 |
| Jeremy Yarwood Chief Scientific Officer | Nov 3, 2026 | Tax withholding | −7,156 | $11.82 | $84.58K | 9,051 |
| Jeremy Yarwood Chief Scientific Officer | Nov 3, 2026 | Option exercise | +16,207 | $11.82 | $191.57K | 16,207 |
| Joe B. Freels Chief Commercial Officer | Nov 2, 2026 | Award | +6,345 | $11.82 | $75.00K | 6,345 |
| Gregory S. Hastings VP, Animal Health | Oct 29, 2026 | Tax withholding | −337 | $12.21 | $4.11K | 33,449 |
| Gregory S. Hastings VP, Animal Health | Oct 29, 2026 | Option exercise | +1,211 | $12.21 | $14.79K | 33,786 |
| Catherine E. Woteki Director | Oct 29, 2026 | Option exercise | +1,776 | $12.21 | $21.68K | 29,507 |
| Rafael A. Rodriguez Director | Oct 29, 2026 | Option exercise | +1,776 | $12.21 | $21.68K | 31,211 |
| Aashima Gupta Director | Oct 29, 2026 | Option exercise | +1,776 | $12.21 | $21.68K | 38,180 |
| Ronald D. Green Director | Oct 29, 2026 | Option exercise | +1,776 | $12.21 | $21.68K | 29,044 |
| Jeffrey D. Capello Director | Oct 29, 2026 | Option exercise | +1,776 | $12.21 | $21.68K | 42,892 |
| James C. Borel Director | Oct 29, 2026 | Option exercise | +1,776 | $12.21 | $21.68K | 106,737 |
| Gregory S. Hastings VP, Animal Health | Oct 14, 2026 | Tax withholding | −80 | $12.00 | $960 | 32,575 |
| Gregory S. Hastings VP, Animal Health | Oct 14, 2026 | Option exercise | +287 | $12.00 | $3.44K | 32,655 |
| Mikheal Nassif CEO, Director | Oct 9, 2026 | Buy | +505 | $11.95 | $6.03K | 1,579 |
| Catherine E. Woteki Director | Oct 1, 2026 | Award | +9,804 | $12.24 | $120.00K | 28,921 |
| Andrea F. Wainer Director | Oct 1, 2026 | Award | +9,804 | $12.24 | $120.00K | 11,834 |
| Rafael A. Rodriguez Director | Oct 1, 2026 | Award | +9,804 | $12.24 | $120.00K | 30,625 |
| Avi Pelossof Director | Oct 1, 2026 | Award | +9,804 | $12.24 | $120.00K | 9,804 |
| Aashima Gupta Director | Oct 1, 2026 | Award | +9,804 | $12.24 | $120.00K | 37,594 |
| Ronald D. Green Director | Oct 1, 2026 | Award | +9,804 | $12.24 | $120.00K | 28,458 |
| Jeffrey D. Capello Director | Oct 1, 2026 | Award | +9,804 | $12.24 | $120.00K | 42,306 |
| James C. Borel Director | Oct 1, 2026 | Award | +9,804 | $12.24 | $120.00K | 106,151 |
| Mikheal Nassif CEO, Director | Aug 19, 2026 | Tax withholding | −20,397 | $11.87 | $242.11K | 25,655 |
| John Patrick Moylan Chief Accounting Officer | Aug 19, 2026 | Tax withholding | −2,365 | $11.87 | $28.07K | 29,331 |
| Richard Bryan Riggsbee CFO | Aug 14, 2026 | Award | +51,502 | $11.65 | $600.00K | 51,502 |
| Tamara A. Ranalli Senior Vice President | Aug 14, 2026 | Award | +25,751 | $11.65 | $300.00K | 25,751 |
| John Patrick Moylan Chief Accounting Officer | Aug 14, 2026 | Award | +8,584 | $11.65 | $100.00K | 32,155 |
| Jennifer Evans Stacey Chief Legal Officer | Aug 14, 2026 | Award | +38,627 | $11.65 | $450.00K | 38,627 |
| Mikheal Nassif CEO, Director | Aug 14, 2026 | Award | +141,631 | $11.65 | $1.65M | 141,631 |
| Mikheal Nassif CEO, Director | Aug 4, 2026 | Buy | +370 | $11.81 | $4.37K | 1,074 |
| John Patrick Moylan Chief Accounting Officer | Jun 3, 2026 | Tax withholding | −2,553 | $8.75 | $22.34K | 23,571 |
| Amy M. Rocklin Former Chief Legal Officer | May 18, 2026 | Tax withholding | −10,241 | $9.29 | $95.14K | 82,182 |
| Amy M. Rocklin Former Chief Legal Officer | May 18, 2026 | Option exercise | +35,183 | $9.29 | $326.85K | 92,423 |
| John Patrick Moylan Chief Accounting Officer | May 4, 2026 | Tax withholding | −1,568 | $9.53 | $14.94K | 17,337 |
| John Patrick Moylan Chief Accounting Officer | May 4, 2026 | Option exercise | +4,558 | $9.53 | $43.44K | 18,905 |
| Jennifer Evans Stacey Chief Legal Officer | May 1, 2026 | Award | +39,349 | $9.53 | $375.00K | 39,349 |
| Mikheal Nassif CEO, Director | Feb 17, 2026 | Buy | +23 | $10.94 | $252 | 704 |
| Mikheal Nassif CEO, Director | Feb 2, 2026 | Buy | +24 | $10.00 | $240 | 681 |
| Mikheal Nassif CEO, Director | Jan 26, 2026 | Buy | +25 | $9.86 | $247 | 657 |
| Mikheal Nassif CEO, Director | Jan 16, 2026 | Buy | +137 | $9.33 | $1.28K | 632 |
| Tamara A. Ranalli Senior Vice President | Jan 7, 2026 | Award | +50,813 | $7.38 | $375.00K | 50,813 |
| Tamara A. Ranalli Senior Vice President | Jan 7, 2026 | Award | +50,813 | $7.38 | $375.00K | 50,813 |
| Tamara A. Ranalli Senior Vice President | Jan 7, 2026 | Award | +50,813 | $7.38 | $375.00K | 50,813 |
| David H. Naemura Former CFO | Dec 1, 2025 | Option exercise | +12,912 | $5.98 | $77.21K | 93,936 |
| David H. Naemura Former CFO | Dec 1, 2025 | Tax withholding | −3,548 | $5.98 | $21.22K | 90,388 |
| Mikheal Nassif CEO, Director | Nov 3, 2025 | Buy | +177 | $6.25 | $1.11K | 495 |
| Richard Bryan Riggsbee CFO | Nov 3, 2025 | Award | +178,855 | $6.29 | $1.12M | 178,855 |
| James C. Borel Director | Oct 27, 2025 | Option exercise | +1,777 | $6.19 | $11.00K | 96,347 |
| Aashima Gupta Director | Oct 27, 2025 | Option exercise | +1,777 | $6.19 | $11.00K | 27,790 |
| Ronald D. Green Director | Oct 27, 2025 | Option exercise | +1,777 | $6.19 | $11.00K | 18,654 |
| Jeffrey D. Capello Director | Oct 27, 2025 | Option exercise | +1,777 | $6.19 | $11.00K | 32,502 |
| Amy M. Rocklin Chief Legal Officer | Oct 27, 2025 | Option exercise | +9,474 | $6.19 | $58.64K | 59,325 |
| Amy M. Rocklin Chief Legal Officer | Oct 27, 2025 | Tax withholding | −2,085 | $6.19 | $12.91K | 57,240 |
| James P. Tobin Director | Oct 27, 2025 | Option exercise | +1,777 | $6.19 | $11.00K | 43,347 |
| Catherine E. Woteki Director | Oct 27, 2025 | Option exercise | +1,777 | $6.19 | $11.00K | 19,117 |
| William T. Boehm Director | Oct 27, 2025 | Option exercise | +3,553 | $6.07 | $21.57K | 47,913 |
| Douglas Edward Jones Former COO | Oct 27, 2025 | Option exercise | +15,504 | $6.19 | $95.97K | 104,362 |
| Douglas Edward Jones Former COO | Oct 27, 2025 | Tax withholding | −3,481 | $6.19 | $21.55K | 100,881 |
| David H. Naemura Chief Financial Officer | Oct 27, 2025 | Tax withholding | −4,261 | $6.19 | $26.38K | 81,024 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Neogen's stock actually held short. Settlement fails (shares not delivered on time) peaked at 253,697 shares on Sep 28, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Jeremy Yarwood Officer | Nov 4, 2026 | 9,051 | $114.64K | Nov 4, 2026 | Restricted Stock Vesting |
| Thierry Bernard Former Director | Oct 28, 2026 | 16,937 | $206.52K | Oct 28, 2026 | Stock Option Exercise |
| Amy M. Rocklin Former Officer | Jun 3, 2026 | 30,337 | $266.56K | Jun 3, 2026 | Option Granted - 06/02/2025 |
| Amy M. Rocklin Former Officer | May 29, 2026 | 87,681 | $805.15K | May 29, 2026 | Option Granted - 08/15/2025 |
| William T. Boehm Director | Aug 18, 2023 | 1,500 | $33.89K | Aug 18, 2023 | Stock Option Exercise |
Congress trades
3 trades in Neogen reported by 2 members of the House
| Member | Type | Traded | Amount | Filed |
|---|---|---|---|---|
| Greg Gianforte MT00 · joint account | Sold (part) | Oct 13, 2020 | $1K–15K | Nov 9, 2020 |
| Donna Shalala FL27 | Sold | Jun 24, 2019 | $1K–15K | Apr 27, 2020 308 days late |
| Greg Gianforte MT00 · joint account | Bought | Jun 12, 2019 | $100K | Jul 1, 2019 |
See a number that looks wrong?